Cargando…

CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients

Ischemic stroke causes mobilization of various groups of progenitor cells from bone marrow to bloodstream and this correlates with the neurological status of stroke patients. The goal of our study was to identify the activity of chosen progenitor/stem cells in the peripheral blood of acute ischemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gójska-Grymajło, Anna, Zieliński, Maciej, Gąsecki, Dariusz, Kowalczyk, Kamil, Kwarciany, Mariusz, Seroczyńska, Barbara, Nyka, Walenty M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097064/
https://www.ncbi.nlm.nih.gov/pubmed/29744773
http://dx.doi.org/10.1007/s12017-018-8494-x
_version_ 1783348228827119616
author Gójska-Grymajło, Anna
Zieliński, Maciej
Gąsecki, Dariusz
Kowalczyk, Kamil
Kwarciany, Mariusz
Seroczyńska, Barbara
Nyka, Walenty M.
author_facet Gójska-Grymajło, Anna
Zieliński, Maciej
Gąsecki, Dariusz
Kowalczyk, Kamil
Kwarciany, Mariusz
Seroczyńska, Barbara
Nyka, Walenty M.
author_sort Gójska-Grymajło, Anna
collection PubMed
description Ischemic stroke causes mobilization of various groups of progenitor cells from bone marrow to bloodstream and this correlates with the neurological status of stroke patients. The goal of our study was to identify the activity of chosen progenitor/stem cells in the peripheral blood of acute ischemic stroke patients in the first 7 days after the incident, through associations between the levels of the cells and clinical features of the patients. Thirty-three acute ischemic stroke patients and 15 non-stroke control subjects had their venous blood collected repeatedly in order to assess the levels of the CD45–CD34 + CD271+, the CD45–CD34 + CXCR4+, the CD45–CD34 + CXCR7+, and the CD45–CD34 + CD133+ stem/progenitor cells by means of flow cytometry. The patients underwent repeated neurological and clinical assessments, pulse wave velocity (PWV) assessment on day 5, and MRI on day 1 and 5 ± 2. The levels of the CD45–CD34 + CXCR7+ and the CD45–CD34 + CD271+ cells were lower in the stroke patients compared with the control subjects. Only the CD45–CD34 + CD271+ cells correlated positively with lesion volume in the second MRI. The levels of the CD45–CD34 + CD133+ cells on day 2 correlated negatively with PWV and NIHSS score on day 9. The patients whose PWV was above 10 m/s had significantly higher levels of the CD45–CD34 + CXCR4+ and the CD45–CD34 + CXCR7+ cells on day 1 than those with PWV below 10 m/s. This study discovers possible activity of the CD45–CD34 + CD271+ progenitor/stem cells during the first 7 days after ischemic stroke, suggests associations of the CD45–CD34 + CD133+ cells with the neurological status of stroke patients, and some activity of the CD45–CD34 + CD133+, the CD45–CD34 + CXCR4+, and the CD45–CD34 + CXCR7+ progenitor/stem cells in the process of arterial remodeling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12017-018-8494-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6097064
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-60970642018-08-24 CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients Gójska-Grymajło, Anna Zieliński, Maciej Gąsecki, Dariusz Kowalczyk, Kamil Kwarciany, Mariusz Seroczyńska, Barbara Nyka, Walenty M. Neuromolecular Med Original Paper Ischemic stroke causes mobilization of various groups of progenitor cells from bone marrow to bloodstream and this correlates with the neurological status of stroke patients. The goal of our study was to identify the activity of chosen progenitor/stem cells in the peripheral blood of acute ischemic stroke patients in the first 7 days after the incident, through associations between the levels of the cells and clinical features of the patients. Thirty-three acute ischemic stroke patients and 15 non-stroke control subjects had their venous blood collected repeatedly in order to assess the levels of the CD45–CD34 + CD271+, the CD45–CD34 + CXCR4+, the CD45–CD34 + CXCR7+, and the CD45–CD34 + CD133+ stem/progenitor cells by means of flow cytometry. The patients underwent repeated neurological and clinical assessments, pulse wave velocity (PWV) assessment on day 5, and MRI on day 1 and 5 ± 2. The levels of the CD45–CD34 + CXCR7+ and the CD45–CD34 + CD271+ cells were lower in the stroke patients compared with the control subjects. Only the CD45–CD34 + CD271+ cells correlated positively with lesion volume in the second MRI. The levels of the CD45–CD34 + CD133+ cells on day 2 correlated negatively with PWV and NIHSS score on day 9. The patients whose PWV was above 10 m/s had significantly higher levels of the CD45–CD34 + CXCR4+ and the CD45–CD34 + CXCR7+ cells on day 1 than those with PWV below 10 m/s. This study discovers possible activity of the CD45–CD34 + CD271+ progenitor/stem cells during the first 7 days after ischemic stroke, suggests associations of the CD45–CD34 + CD133+ cells with the neurological status of stroke patients, and some activity of the CD45–CD34 + CD133+, the CD45–CD34 + CXCR4+, and the CD45–CD34 + CXCR7+ progenitor/stem cells in the process of arterial remodeling. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12017-018-8494-x) contains supplementary material, which is available to authorized users. Springer US 2018-05-09 2018 /pmc/articles/PMC6097064/ /pubmed/29744773 http://dx.doi.org/10.1007/s12017-018-8494-x Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Gójska-Grymajło, Anna
Zieliński, Maciej
Gąsecki, Dariusz
Kowalczyk, Kamil
Kwarciany, Mariusz
Seroczyńska, Barbara
Nyka, Walenty M.
CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
title CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
title_full CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
title_fullStr CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
title_full_unstemmed CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
title_short CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
title_sort cd271+, cxcr7+, cxcr4+, and cd133+ stem/progenitor cells and clinical characteristics of acute ischemic stroke patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097064/
https://www.ncbi.nlm.nih.gov/pubmed/29744773
http://dx.doi.org/10.1007/s12017-018-8494-x
work_keys_str_mv AT gojskagrymajłoanna cd271cxcr7cxcr4andcd133stemprogenitorcellsandclinicalcharacteristicsofacuteischemicstrokepatients
AT zielinskimaciej cd271cxcr7cxcr4andcd133stemprogenitorcellsandclinicalcharacteristicsofacuteischemicstrokepatients
AT gaseckidariusz cd271cxcr7cxcr4andcd133stemprogenitorcellsandclinicalcharacteristicsofacuteischemicstrokepatients
AT kowalczykkamil cd271cxcr7cxcr4andcd133stemprogenitorcellsandclinicalcharacteristicsofacuteischemicstrokepatients
AT kwarcianymariusz cd271cxcr7cxcr4andcd133stemprogenitorcellsandclinicalcharacteristicsofacuteischemicstrokepatients
AT seroczynskabarbara cd271cxcr7cxcr4andcd133stemprogenitorcellsandclinicalcharacteristicsofacuteischemicstrokepatients
AT nykawalentym cd271cxcr7cxcr4andcd133stemprogenitorcellsandclinicalcharacteristicsofacuteischemicstrokepatients